Corporate team assist Baywater Healthcare on acquisition

Acquisition Of Intus Healthcare

Baywater Healthcare has completed the acquisition of Intus Healthcare, a leading online provider of therapeutic medical products and diagnostic studies for the treatment of sleep disordered breathing.

This marks the second deal that Turner Parkinson have advised the North West based business in 2018, following their acquisition by Bastide Group in January.

Head of Corporate James Sheridan lead the team, with assistance from David Hayes, Ryan Tweedale and Matthew Hitchen.

James previously spoke of Turner Parkinson's ongoing relationship with Baywater: "We worked with management in 2013 when the business was acquired from Air Products, and have looked after the business’ strategic and day to day legal needs ever since."

Intus, founded by the current Managing Director Martin Heller over ten years ago, has established a niche position in the UK healthcare market, supplying both private patients and NHS sleep clinics with a wide variety of equipment to treat Obstructive Sleep Apnoea.

This transaction confirms Baywater Healthcare’s desire to expand their expertise into the online private healthcare and sleep markets.

Adam Sullivan, Baywater Healthcare's CEO commented; “I’ve known Martin for several years and admired how he has created a very successful business in this growing sector using his entrepreneurial flair.  We look forward to working closely with the Intus team to continue the fantastic work they have done in delivering such impressive growth.”
Martin Heller stated; “Baywater Healthcare was a natural fit for my business, the company possess very similar values to ours and are committed to developing innovative solutions for patients.  People are now really starting to understand how important sleep is to maintaining good health and the treatment model we have developed over many years is perfectly positioned to support the increasing need for these services in the future.”